GH Research (GHRS) Prepaid Assets (2021 - 2025)
GH Research (GHRS) recorded quarterly Prepaid Assets of $5.3 million in Q4 2025, down 16.15% quarter-over-quarter from $6.3 million in Q3 2025, and up 7.49% on a YoY basis from $4.9 million in Q4 2024.
GH Research (GHRS) Prepaid Assets (2021 - 2025) Analysis & Trends
GH Research's Prepaid Assets history runs 5 years deep, the most recent figure standing at $5.3 million for Q4 2025.
- In Q4 2025, Prepaid Assets rose 7.49% year-over-year to $5.3 million; the TTM figure through Dec 2025 stood at $5.3 million (up 7.49% YoY), while the FY2025 annual figure was $5.3 million, up 7.49% from the prior year.
- Prepaid Assets was $5.3 million for Q4 2025 at GH Research, down from $6.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $6.3 million in Q3 2025 to a low of $856000.0 in Q2 2022.
- Historically, Prepaid Assets has averaged $3.1 million across 5 years, with a median of $2.7 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets slumped 35.63% in 2022, then surged 119.58% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $2.9 million in 2021, then dropped by 11.86% to $2.6 million in 2022, then retreated by 13.69% to $2.2 million in 2023, then surged by 119.58% to $4.9 million in 2024, then increased by 7.49% to $5.3 million in 2025.
- The last three Prepaid Assets figures came in at $5.3 million (Q4 2025), $6.3 million (Q3 2025), and $2.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.27 Mn |
| Sep 30, 2025 | 6.28 Mn |
| Jun 30, 2025 | 2.35 Mn |
| Mar 31, 2025 | 3.32 Mn |
| Dec 31, 2024 | 4.90 Mn |
| Sep 30, 2024 | 4.91 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 2.62 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Sep 30, 2023 | 2.77 Mn |
| Jun 30, 2023 | 1.02 Mn |
| Mar 31, 2023 | 1.90 Mn |
| Dec 31, 2022 | 2.59 Mn |
| Sep 30, 2022 | 3.10 Mn |
| Jun 30, 2022 | 856,000.00 |
| Mar 31, 2022 | 2.71 Mn |
| Dec 31, 2021 | 2.93 Mn |
| Sep 30, 2021 | 4.82 Mn |